NCT05309980

Brief Summary

In this before-after monocenter study, the authors teste the hypothesis that the implementation of a dedicated shock team could improve the outcome of patients with refractory cardiogenic shock assisted by mechanical circulatory support.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 4, 2022

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2022

Completed
Last Updated

April 10, 2023

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

December 8, 2021

Last Update Submit

April 7, 2023

Conditions

Keywords

Extra Corporeal Membrane OxygenationCardiogenic ShockImpellaShock TeamLong Term Mechanical Circulatory Support

Outcome Measures

Primary Outcomes (1)

  • Vital status

    Proportion of patients alive

    One year after short term mechanical circulatory support initiation

Secondary Outcomes (19)

  • Vital status

    30 days after short term mechanical circulatory support initiation

  • Vital status

    3 months after short term mechanical circulatory support initiation

  • Vital status

    6 months after short term mechanical circulatory support initiation

  • Lenght of stay

    up to Intensive Care Unit discharge, an average of 15 days

  • Lenght of stay

    up to one year

  • +14 more secondary outcomes

Study Arms (2)

Without Shock Team

Before January 2013, patients with refractory cardiogenic shock were implanted with short term mechanical circulatory device without involvment of a dedicated shock team

Other: standard of care

With Shock Team

After April 2013, patients with refractory cardiogenic shock were implanted with short term mechanical circulatory device following a collegial meeting of a shock team (cardiac surgeon, cardiologist, intensivist) using a common algorythm.

Other: standard of care

Interventions

retrospective study : standard of care

With Shock TeamWithout Shock Team

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Consecutive patients with refractory cardiogenic shock treated with short term mechanical circulatory support between January 2007 to April 2019. A two months wash out period following shock team initiation (February and March 2013) has been set.

You may qualify if:

  • Diagnosis of cardiogenic shock
  • \>1 sign of refractory cardiogenic shock : Dobutamine \>10µg/kg/mn, epinephrine\>0.25µg/kg/mn or Milrinone \> 0.5µg/kg/mn ; ScvO2\<55% ; pO2/FiO2\<100
  • No major counter indication to short term mechanical circulatory support : SOFA score \> 15, prolonged cardiac arrest, severe chronic disease, direct LVAD implantation or heart transplantation, counter indication for systemic anticoagulation

You may not qualify if:

  • Age \< 18years
  • Post cardiotomy cardiogenic shock
  • Implantation of Impella 2.5 alone
  • Implantation of Intra Aortic Balloon Pump alone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bordeaux University Hospital

Pessac, 33604, France

Location

MeSH Terms

Conditions

Shock, Cardiogenic

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisShock

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Alexandre Ouattara, MD, PhD

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

December 8, 2021

First Posted

April 4, 2022

Study Start

April 1, 2021

Primary Completion

April 1, 2022

Study Completion

April 15, 2022

Last Updated

April 10, 2023

Record last verified: 2022-03

Locations